3M CO (MMM) Operating Margin
- Operating margin · 12 months: Value 18.36%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 18.36% | Operating income / revenue. Period ending 2026-06-30. $4.62B ÷ $25.18B × 100 ≈ 18.36% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 4.62B USD | Operating Income (Loss) |
| Revenue | 25.18B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | 3.59B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4.62B | $25.18B | (m) | (m) | $3.59B | 18.36% |
| 2026-03-31 | $4.78B | $25.02B | (m) | (m) | $3.80B | 19.10% |
| 2025-12-31 | $4.63B | $24.95B | (m) | (m) | $4.00B | 18.55% |
| 2025-09-30 | $4.92B | $24.82B | (m) | (m) | $3.93B | 19.81% |
| 2025-06-30 | $4.79B | $24.60B | (m) | (m) | $4.17B | 19.46% |
| 2025-03-31 | $4.92B | $24.51B | (m) | (m) | $4.04B | 20.07% |
| 2024-12-31 | $4.82B | $24.57B | (m) | $700.00M | $4.22B | 19.62% |
| 2024-09-30 | $6.20B | $32.64B | (m) | (m) | $6.67B | 18.99% |
| 2024-06-30 | $1.78B | $32.61B | (m) | (m) | $11.02B | 5.47% |
| 2024-03-31 | $-8.87B | $32.65B | (m) | (m) | $21.56B | -27.16% |
| 2023-12-31 | $-9.13B | $32.68B | (m) | $1.00B | $21.53B | -27.93% |
| 2023-09-30 | $-9.74B | $32.75B | (m) | (m) | $22.05B | -29.74% |
| 2023-06-30 | $-2.93B | $33.05B | (m) | (m) | $18.05B | -8.86% |
| 2023-03-31 | $6.14B | $33.43B | (m) | (m) | $8.87B | 18.36% |
| 2022-12-31 | $6.54B | $34.23B | (m) | $1.10B | $9.05B | 19.10% |
| 2022-09-30 | $7.52B | $34.76B | (m) | (m) | $8.73B | 21.64% |
| 2022-06-30 | $5.16B | $35.09B | (m) | (m) | $8.55B | 14.69% |
| 2022-03-31 | $7.02B | $35.33B | (m) | (m) | $7.27B | 19.86% |
| 2021-12-31 | $7.37B | $35.35B | (m) | $1.24B | $7.20B | 20.84% |
| 2021-09-30 | $7.60B | $35.33B | (m) | (m) | $7.26B | 21.52% |
| 2021-06-30 | $7.72B | $34.73B | (m) | (m) | $7.12B | 22.23% |
| 2021-03-31 | $7.49B | $32.96B | (m) | (m) | $6.97B | 22.73% |
| 2020-12-31 | $7.16B | $32.18B | (m) | $1.15B | $6.93B | 22.25% |
| 2020-09-30 | $6.64B | $31.71B | (m) | (m) | $6.98B | 20.93% |
| 2020-06-30 | $6.74B | $31.35B | (m) | (m) | $6.76B | 21.49% |
| 2020-03-31 | $6.70B | $32.35B | (m) | (m) | $6.85B | 20.72% |
| 2019-12-31 | $6.17B | $32.14B | (m) | $1.25B | $7.03B | 19.21% |
| 2019-09-30 | $6.63B | $31.97B | (m) | (m) | $6.77B | 20.74% |
| 2019-06-30 | $6.64B | $32.13B | (m) | (m) | $6.86B | 20.66% |
| 2019-03-31 | $7.34B | $32.35B | (m) | (m) | $6.98B | 22.68% |
| 2018-12-31 | $7.21B | $32.77B | (m) | $1.25B | $7.60B | 22.00% |
| 2018-09-30 | $7.21B | $32.81B | (m) | (m) | $7.67B | 21.98% |
| 2018-06-30 | $7.21B | $32.83B | (m) | (m) | $7.76B | 21.95% |
| 2018-03-31 | $6.96B | $32.25B | (m) | (m) | $7.58B | 21.57% |
| 2017-12-31 | $7.82B | $31.66B | (m) | $1.33B | $6.57B | 24.70% |
| 2017-09-30 | $7.66B | $31.00B | (m) | (m) | $6.32B | 24.73% |
| 2017-06-30 | $7.53B | $30.53B | (m) | (m) | $6.22B | 24.65% |
| 2017-03-31 | $7.21B | $30.39B | (m) | (m) | $6.19B | 23.73% |
| 2016-12-31 | $7.22B | $30.11B | (m) | $1.23B | $6.11B | 23.99% |
| 2016-09-30 | $7.06B | $30.08B | (m) | (m) | $6.12B | 23.47% |
| 2016-06-30 | $7.03B | $30.08B | (m) | (m) | $6.12B | 23.37% |
| 2016-03-31 | $7.00B | $30.11B | (m) | (m) | $6.11B | 23.27% |
| 2015-12-31 | $6.95B | $30.27B | (m) | $1.22B | $6.18B | 22.94% |
| 2015-09-30 | $7.11B | $30.70B | (m) | (m) | $6.24B | 23.16% |
| 2015-06-30 | $7.13B | $31.12B | (m) | (m) | $6.30B | 22.92% |
| 2015-03-31 | $7.15B | $31.57B | (m) | (m) | $6.40B | 22.65% |
| 2014-12-31 | $7.13B | $31.82B | (m) | $1.19B | $6.47B | 22.42% |
| 2014-09-30 | $7.05B | $31.67B | (m) | (m) | $6.45B | 22.27% |
| 2014-06-30 | $6.89B | $31.45B | (m) | (m) | $6.46B | 21.91% |
| 2014-03-31 | $6.74B | $31.07B | (m) | (m) | $6.43B | 21.68% |
| 2013-12-31 | $6.67B | $30.87B | (m) | $1.15B | $6.38B | 21.59% |
| 2013-09-30 | $6.53B | $30.69B | (m) | (m) | $6.34B | 21.28% |
| 2013-06-30 | $6.47B | $30.27B | (m) | (m) | $6.22B | 21.37% |
| 2013-03-31 | $6.50B | $30.05B | (m) | (m) | $6.14B | 21.61% |
| 2012-12-31 | $6.48B | $29.90B | (m) | $1.08B | $6.10B | 21.68% |
| 2012-09-30 | $6.40B | $29.61B | (m) | (m) | $6.09B | 21.63% |
| 2012-06-30 | $6.31B | $29.64B | (m) | (m) | $6.14B | 21.28% |
| 2012-03-31 | $6.23B | $29.79B | (m) | (m) | $6.19B | 20.93% |
| 2011-12-31 | $6.18B | $29.61B | (m) | $1.04B | $6.17B | 20.86% |
| 2011-09-30 | $6.12B | $29.23B | (m) | (m) | $6.09B | 20.92% |
| 2011-06-30 | $6.11B | $28.57B | (m) | (m) | $5.92B | 21.38% |
| 2011-03-31 | $6.05B | $27.63B | (m) | (m) | $5.69B | 21.90% |
| 2010-12-31 | $5.92B | $26.66B | (m) | $919.00M | $5.48B | 22.20% |
| 2010-09-30 | $5.96B | $26.07B | (m) | (m) | $5.30B | 22.85% |
| 2010-06-30 | $5.86B | $25.39B | (m) | (m) | $5.15B | 23.08% |
| 2010-03-31 | $5.46B | $24.38B | (m) | (m) | $5.04B | 22.38% |
| 2009-12-31 | $4.81B | $23.12B | (m) | (m) | $4.91B | 20.82% |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $5.22B | $25.27B | (m) | (m) | $5.25B | 20.65% |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | $6.19B | $24.46B | (m) | (m) | $5.01B | 25.32% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |